| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| EAGLE PHARMACEUTICALS, INC. | Interim Executive Chair & PEO, Director | Common Stock | 10,360 | $53,147 | $5.13 | 27 Oct 2023 | Direct |
| EAGLE PHARMACEUTICALS, INC. | Interim Executive Chair & PEO, Director | Employee Stock Option (right to buy) | 293,000 | 21 Dec 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| EGRX | EAGLE PHARMACEUTICALS, INC. | 21 Dec 2023 | 1 | $0 | 4 | Interim Executive Chair & PEO, Director | 22 Dec 2023, 19:00 |
| EGRX | EAGLE PHARMACEUTICALS, INC. | 27 Oct 2023 | 2 | +$46,238 | 4 | Director | 31 Oct 2023, 17:41 |
| EGRX | EAGLE PHARMACEUTICALS, INC. | 07 Mar 2023 | 1 | $0 | 4 | Director | 09 Mar 2023, 20:03 |
| EGRX | EAGLE PHARMACEUTICALS, INC. | 28 Feb 2022 | 1 | $0 | 4 | Director | 02 Mar 2022, 16:57 |